Gene · 2532
ACKR1: atypical chemokine receptor 1 (Duffy blood group)
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ACKR1: atypical chemokine receptor 1 (Duffy blood group). Genes, record 2532. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2532
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16570 | Atypical chemokine receptor 1 | 336 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 44371 | Q16570 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44373 | Q16570 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44375 | Q16570 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 16716 | Q16570 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 232 | Q16570 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 232 | Q16570 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7878 | Q16570 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7880 | Q16570 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 16716 | Q16570 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 16716 | Q16570 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,590
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ACKR1 papers | Newest fiscal year |
|---|---|---|---|
| P30EY001792 | P30 Core Grant for Vision Research | 15 | 2025 |
| P30AI045008 | Penn Center for AIDS Research | 10 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 9 | 2025 |
| R01AI139618 | Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes | 9 | 2025 |
| R01EY019896 | Developing A Tissue-Targeted Ocular HSV Therapeutic Vaccine | 7 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 7 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 7 | 2025 |
| ZIAAI000548 | Development Of Vaccines For Genital Herpes Simplex Infection | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| R01EY024710 | A new molecular therapy against ocular herpes | 6 | 2025 |
1 to 10 of 2,590Source NIH's project files
See all 2,590 nih grantsPapers3,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor Vascular Features and Colorectal Cancer-Specific Mortality. | JAMA Netw Open | 2026 | 42804694 | PubTator, text mining | PubMed |
| Malaria-Related Host Genetic Variation in an Endemic Population of Southern Senegal. | Int J Mol Sci | 2026 | 42794552 | PubTator, text mining | PubMed |
| Atypical Chemokine Receptor DARC/ACKR1 Is Expressed Selectively by Neurons with Regional Heterogeneity and Protects against Neuroinflammation and Cognitive Impairment. | bioRxiv | 2026 | 42779766 | PubTator, text mining | PubMed |
| Blood Cell Counts and the Duffy Null Phenotype: Beyond Neutropenia. | Int J Lab Hematol | 2026 | 42678004 | PubTator, text mining | PubMed |
| LATS1/2 inactivation drives a distinct venous endothelial cell response that contributes to fibrotic remodeling of the lung. | Sci Adv | 2026 | 42664350 | PubTator, text mining | PubMed |
| A CHO-Expressed Pseudorabies Virus gD Subunit Vaccine Elicits Potent Neutralizing Antibodies and Confers Complete Protection Against Lethal Challenge in Mice. | Vaccines (Basel) | 2026 | 42646727 | PubTator, text mining | PubMed |
| Antiviral activity of biogenic silver nanoparticles against HSV-1: integrating computational modeling and experimental validation. | Iran J Microbiol | 2026 | 42626032 | PubTator, text mining | PubMed |
| ACKR1-expressing venous endothelial cells establish a pro-fibrotic niche in pulmonary fibrosis. | bioRxiv | 2026 | 42620057 | PubTator, text mining | PubMed |
| Enhanced salivary correlation between Streptococcus mutans and herpes simplex virus-1 in oral squamous cell carcinoma: a case-control study. | BMC Oral Health | 2026 | 42601617 | PubTator, text mining | PubMed |
| Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis. | Invest Ophthalmol Vis Sci | 2026 | 42530913 | PubTator, text mining | PubMed |
1 to 10 of 3,550
See all 3,550 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2532
GET https://conductscience.org/api/genes/v1/2532/patents?page=2